Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 8 studies | 20% ± 4% | |
endothelial cell | 5 studies | 22% ± 6% | |
ciliated cell | 5 studies | 21% ± 5% | |
B cell | 4 studies | 20% ± 3% | |
epithelial cell | 4 studies | 25% ± 6% | |
GABAergic neuron | 3 studies | 22% ± 4% | |
glutamatergic neuron | 3 studies | 33% ± 8% | |
basal cell | 3 studies | 22% ± 4% | |
transit amplifying cell | 3 studies | 20% ± 6% | |
neuron | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1136.60 | 459 / 459 | 100% | 21.53 | 1118 / 1118 |
esophagus | 100% | 973.44 | 1445 / 1445 | 100% | 16.53 | 183 / 183 |
ovary | 100% | 987.47 | 180 / 180 | 100% | 12.80 | 430 / 430 |
prostate | 100% | 1019.81 | 245 / 245 | 100% | 18.86 | 502 / 502 |
lung | 100% | 895.01 | 577 / 578 | 100% | 16.90 | 1155 / 1155 |
brain | 100% | 779.80 | 2637 / 2642 | 100% | 21.81 | 705 / 705 |
thymus | 100% | 1301.81 | 653 / 653 | 100% | 22.57 | 603 / 605 |
uterus | 100% | 1165.58 | 170 / 170 | 100% | 22.12 | 457 / 459 |
intestine | 100% | 1123.71 | 966 / 966 | 99% | 15.88 | 524 / 527 |
bladder | 100% | 1122.14 | 21 / 21 | 99% | 16.71 | 501 / 504 |
stomach | 100% | 730.65 | 359 / 359 | 99% | 14.54 | 284 / 286 |
pancreas | 98% | 510.00 | 323 / 328 | 99% | 16.26 | 177 / 178 |
kidney | 100% | 673.65 | 89 / 89 | 98% | 13.07 | 882 / 901 |
skin | 100% | 978.58 | 1809 / 1809 | 98% | 17.20 | 462 / 472 |
adrenal gland | 100% | 572.41 | 257 / 258 | 96% | 10.77 | 221 / 230 |
liver | 88% | 236.81 | 200 / 226 | 87% | 6.71 | 355 / 406 |
adipose | 100% | 1058.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1137.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.50 | 29 / 29 |
muscle | 100% | 1077.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 969.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.92 | 1 / 1 |
heart | 98% | 885.54 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 9.39 | 74 / 80 |
peripheral blood | 89% | 718.91 | 828 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006363 | Biological process | termination of RNA polymerase I transcription |
GO_0006353 | Biological process | DNA-templated transcription termination |
GO_0008156 | Biological process | negative regulation of DNA replication |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | TTF1 |
Protein name | Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I) Transcription termination factor 1 |
Synonyms | |
Description | FUNCTION: Multifunctional nucleolar protein that terminates ribosomal gene transcription, mediates replication fork arrest and regulates RNA polymerase I transcription on chromatin. Plays a dual role in rDNA regulation, being involved in both activation and silencing of rDNA transcription. Interaction with BAZ2A/TIP5 recovers DNA-binding activity. . |
Accessions | ENST00000334270.3 Q15361 A0A087WY09 ENST00000612514.4 |